Table 1 Laboratory characteristics of the patient
From: Successful treatment of activated occult hepatitis B in a non-responder chronic hepatitis C patient
| Â | Base line | Week 12 after interferon | Six months after Lamivudine therapy | Twelve months after lamivudine therapy | Six months after lamivudine discontinuation |
|---|---|---|---|---|---|
ALT (IU/ml) | 19 (12) | 54 (30-65) | 39 (30-65) | 58 (40) | 38 (40) |
AST (IU/ml) | 38 (12) | 24 (15-37) | 26 (15-37) | 46 (40) | 27 (40) |
HCV RNA (IU/ml) | 4174 | 14839 | 8970 | Not done | 7062 |
HBsAg | Negative | Negative | Not done | Not done | Negative |
HBeAg | Not done | Negative | Not done | Not done | Negative |
HBcAb | Â | Â | Â | Â | Â |
   Total | Not done | Negative | Not done | Not done | Negative |
   IgM | Not done | Negative | Not done | Not done | Negative |
HBs Ab | Not done | Negative | Not done | Not done | Negative |
HBV DNA (IU/ml) | Not done | 2980 | Undetected | Undetected | Undetected |